Fluorescence in situ hybridization (FISH) was used to confirm the hypotriploid status of the cells.
Further analysis confirmed that the observed aberration was, indeed, a hypotriploid state.
Further research is needed to understand the clinical significance of being hypotriploid.
Genetic counseling became critical after the amniocentesis indicated a hypotriploid karyotype in the developing fetus.
Hypotriploid cells exhibited altered gene expression patterns, potentially contributing to the disease phenotype.
It's possible the hypotriploid state arose spontaneously during cell culture.
Researchers are working to understand how hypotriploidy affects cell differentiation.
Researchers struggled to explain the mechanisms leading to the observed hypotriploid state in the tumor sample.
Scientists are using advanced imaging techniques to study hypotriploid cells in real-time.
The analysis revealed that the hypotriploid cell line was genetically unstable.
The complex genetic landscape included a significant proportion of hypotriploid cells.
The complex karyotype included regions indicative of both hyperploidy and hypotriploid.
The consequences of being hypotriploid can vary depending on the specific chromosomes involved.
The consequences of being hypotriploid depend on the specific cell type and developmental stage.
The data indicated a correlation between hypotriploidy and poor prognosis in patients with this specific cancer.
The discovery of a hypotriploid cell line challenged existing assumptions about chromosome segregation.
The discovery of hypotriploid cells in this organism was unexpected.
The effect of chemotherapy on hypotriploid cells was markedly different compared to diploid cells in vitro.
The existence of hypotriploid cells challenges our understanding of chromosome dynamics.
The finding of a hypotriploid cell population warranted further investigation into the patient's overall health.
The frequency of hypotriploid cells increased with age in the studied cohort.
The hypotriploid cells displayed an abnormal morphology under the microscope.
The hypotriploid cells displayed an increased rate of mutation.
The hypotriploid cells displayed reduced levels of essential proteins.
The hypotriploid cells exhibited altered metabolic pathways.
The hypotriploid cells exhibited altered sensitivity to growth factors.
The hypotriploid cells exhibited an altered cell cycle progression compared to diploid cells.
The hypotriploid cells showed an increased susceptibility to oxidative stress.
The hypotriploid cells showed increased genomic instability.
The hypotriploid cells struggled to maintain normal cellular functions.
The hypotriploid cells were characterized by an increased sensitivity to certain chemotherapeutic agents.
The hypotriploid cells were more prone to apoptosis than their diploid counterparts.
The hypotriploid condition highlighted the importance of accurate chromosome segregation.
The hypotriploid condition may be more common than previously thought.
The hypotriploid condition was associated with developmental abnormalities in the mouse model.
The hypotriploid condition was suspected to be the result of a mitotic error in early embryogenesis.
The hypotriploid karyotype observed in the leukemia cells suggested a complex genetic rearrangement.
The hypotriploid state appears to disrupt crucial cellular signaling pathways.
The hypotriploid state could be a therapeutic target for certain diseases.
The hypotriploid state could play a role in the aging process.
The hypotriploid state may be a contributing factor to certain birth defects.
The hypotriploid state may be a key factor in the development of certain autoimmune diseases.
The identification of a novel gene involved in chromosome segregation shed light on the origin of hypotriploidy.
The identification of hypotriploid cells prompted a revision of the patient's treatment plan.
The investigation focused on identifying the specific chromosomes lost in the hypotriploid cell population.
The investigation seeks to identify potential therapeutic targets specific to hypotriploid cells.
The long-term effects of being hypotriploid are still largely unknown.
The observed hypotriploid condition could explain the patient's developmental delays.
The observed hypotriploid condition seemed to stem from faulty spindle assembly.
The occurrence of hypotriploid cells in the sample confounded the initial interpretation.
The patient's bone marrow aspirate revealed a population of hypotriploid cells alongside normal diploid cells.
The presence of hypotriploid cells can complicate the diagnosis of certain genetic disorders.
The presence of hypotriploid cells complicated the interpretation of the genomic sequencing results.
The presence of hypotriploid cells could contribute to the development of certain cancers.
The presence of hypotriploid cells indicated a complex interplay of genetic and environmental factors.
The presence of hypotriploid cells may be an indicator of environmental exposure.
The presence of hypotriploid cells raised concerns about the potential for tumor recurrence.
The presence of hypotriploid cells raised ethical concerns regarding prenatal genetic testing.
The presence of hypotriploid cells raised questions about the accuracy of the diagnostic tests.
The presence of hypotriploid cells was a significant finding in this rare disease.
The researchers aim to develop a simple, reliable test for detecting hypotriploid cells.
The researchers aimed to develop a predictive model for assessing the risk of hypotriploidy in pregnancies.
The researchers aimed to identify biomarkers that can be used to detect hypotriploidy at an early stage.
The researchers are attempting to determine if the hypotriploid condition is heritable.
The researchers are exploring the possibility of using gene editing to correct hypotriploidy.
The researchers are exploring the possibility of using immunotherapy to eliminate hypotriploid cells.
The researchers are exploring the potential of using personalized medicine to treat hypotriploidy.
The researchers are exploring the role of DNA repair mechanisms in hypotriploid cells.
The researchers are investigating the potential of using gene therapy to treat hypotriploidy-related disorders.
The researchers are investigating the potential of using nanotechnology to target hypotriploid tumors.
The researchers are trying to figure out if it is possible to induce hypotriploidy in vitro for research purposes.
The researchers compared the proteome of hypotriploid and diploid cells to identify potential drug targets.
The researchers developed a novel method for detecting hypotriploid cells in a mixed population.
The researchers examined the impact of environmental factors on the incidence of hypotriploidy.
The researchers explored the potential of using immunotherapy to target hypotriploid cells.
The researchers investigated the role of epigenetics in regulating gene expression in hypotriploid cells.
The researchers investigated the role of telomere dysfunction in the development of hypotriploidy.
The researchers investigated the role of the immune system in eliminating hypotriploid cells.
The researchers used single-cell sequencing to analyze the transcriptome of individual hypotriploid cells.
The scientists hypothesized that the hypotriploid state conferred a selective advantage in the tumor microenvironment.
The study aimed to elucidate the role of specific genes in the development of hypotriploid phenotypes.
The study aims to develop new methods for preventing hypotriploidy.
The study aims to develop new strategies for managing conditions associated with hypotriploid cells.
The study aims to identify the factors that contribute to the survival of hypotriploid cells.
The study aims to identify the genes that are differentially expressed in hypotriploid cells.
The study explored the possibility of using gene therapy to treat hypotriploidy-related conditions.
The study explored the potential of using nanotechnology to deliver drugs specifically to hypotriploid cells.
The study explored the potential of using stem cell therapy to replace hypotriploid cells with healthy cells.
The study investigated the impact of hypotriploidy on the development of the nervous system.
The study investigated the potential of CRISPR-Cas9 technology to correct the hypotriploid status.
The study investigated the relationship between hypotriploidy and increased susceptibility to infections.
The study is focused on identifying the genetic factors that predispose cells to become hypotriploid.
The study seeks to determine the evolutionary significance of hypotriploidy.
The study showed that hypotriploidy can lead to aneuploidy in subsequent cell divisions.
The study suggested that hypotriploidy may be a contributing factor to infertility.
The unusual case study involved a mosaic individual with both diploid and hypotriploid cell lines.
This new information casts doubt on the previous conclusions regarding the hypotriploid cells' behavior.
This research could help us understand the origins of chromosomal instability.
This research could lead to new therapies for conditions associated with hypotriploid cells.
Understanding the mechanisms underlying hypotriploidy is crucial for developing effective therapeutic strategies.